Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ISRCTN74292348) titled 'Effects of GingerT3(R), a specialized ginger extract, supplementation for mild to moderate joint pain' on May 7.
Study Type: Interventional
Study Design:
Randomized placebo-controlled double-blind parallel-group and repeated-measures design (Quality of life, Treatment, Safety, Efficacy)
Primary Sponsor: SpecNova
Condition:
Mild to severe joint and muscle pain
Musculoskeletal Diseases
Intervention:
Thirty men and women (average age 56.0±9.0 years
height 164.4±14 cm
weight 86.5±20.9 kg
Recruitment Status: Not Recruiting
Phase: Not Applicable
Date of First Enrollment: 06/04/2023
Target Sam...